You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 10 No. 4, April 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (42)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Brain Scanning With Chlormerodrin Hg197 and Chlormerodrin Hg203

ALBERT L. RHOTON, JR., MD; ANNA-MARIE CARLSSON, MD; MICHEL M. TER-POGOSSIAN, PhD

Arch Neurol. 1964;10(4):369-375.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Early experience in brain tumor localization at this institution, utilizing diiodofluorescein I131 and scintillation counter "spot checking," proved this technique suitable only for screening.1,2 Further progress elsewhere included development of scanning scintillation detectors,3 photographic recording,4,5 and more suitable scanning agents including radiomercury-labeled chlormerodrin (Neohydrin).6 Our present program utilizing the above refinements in equipment and radiomercury-tagged chlormerodrin has proved useful in the localization of intracranial tumors in the majority of cases prior to contrast studies.

The isotope initially used was Hg203 tagged to chlormerodrin. This compound was introduced in 1959 as an agent for brain scanning by Blau and Bender6 who found it significantly better than albumin I131.7 Hg203 decays with a half life of 45.8 days with the emission of a low energy β-particle to an excited state of Tl203, which in turn emits a single 0.28 mev {gamma}-ray. . . . [Full Text PDF of this Article]


Author Affiliations

ST. LOUIS

From the Division of Neurological Surgery, the Central Clinical Isotope Laboratory and the Mallinckrodt Institute of Radiology, Washington University School of Medicine.

Fellow in Neurological Surgery (Dr. Rhoton); Central Clinical Isotope Laboratory (Dr. Carlsson); Professor of Radiophysics, the Mallinckrodt Institute of Radiology (Dr. Ter-Pogossian).


Footnotes

Submitted for publication Sept 9, 1963; accepted Oct 15.

Aided by a grant from the Allen P. and Josephine B. Green Foundation.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.